Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells
- PMID: 16168713
- DOI: 10.1016/j.ymthe.2005.07.698
Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells
Abstract
We examined the ability of a HIV-1-based vector (VRX494) encoding a 937-bp antisense HIV-1 envelope sequence to inhibit the replication of chimeric SIV/HIV-1 viruses encoding the HIV-1 envelope. Challenge of VRX494-transduced CEMx174 cells resulted in potent inhibition of HIV-1 and several SHIV strains. To evaluate the potential efficacy of the VRX494 vector for stem cell gene therapy, rhesus CD34(+) bone marrow cells were transduced with VRX494 and then cultured on thymus stroma to induce T cell differentiation. Transduction conditions for CD34(+) cells were optimized to yield high transduction efficiency with minimal effective multiplicity of infection. Purified CD4(+) GFP(+) T cells derived from VRX494-transduced CD34(+) cells strongly inhibited SHIV HXBC2P 3.2 and SHIV 89.6P replication compared to controls. Southern blot analysis of VRX494-transduced T cell clones revealed a subset of cells with multiple proviral copies per cell. Expression of GFP and the antisense inhibitor in VRX494-transduced cells was upregulated by Tat. Analysis of HIV-1 envelope sequences in VRX494-transduced cells revealed modifications consistent with those mediated by double-stranded RNA-dependent adenosine deaminase. These results indicate that the macaque/SHIV model should serve as a useful preclinical model to evaluate this lentiviral vector expressing an HIV-1 antisense inhibitor for stem cell gene therapy for AIDS.
Similar articles
-
Potent inhibition of simian immunodeficiency virus (SIV) replication by an SIV-based lentiviral vector expressing antisense Env.Hum Gene Ther. 2007 Jul;18(7):653-64. doi: 10.1089/hum.2007.003. Hum Gene Ther. 2007. PMID: 17600461
-
Sustained transgene expression by human cord blood derived CD34+ cells transduced with simian immunodeficiency virus agmTYO1-based vectors carrying the human coagulation factor VIII gene in NOD/SCID mice.J Gene Med. 2004 Oct;6(10):1049-60. doi: 10.1002/jgm.609. J Gene Med. 2004. PMID: 15386735
-
Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors.Mol Ther. 2000 Jul;2(1):71-80. doi: 10.1006/mthe.2000.0094. Mol Ther. 2000. PMID: 10899830
-
RNAi in combination with a ribozyme and TAR decoy for treatment of HIV infection in hematopoietic cell gene therapy.Ann N Y Acad Sci. 2006 Oct;1082:172-9. doi: 10.1196/annals.1348.006. Ann N Y Acad Sci. 2006. PMID: 17145937 Review.
-
Gene therapy for HIV/AIDS: the potential for a new therapeutic regimen.J Gene Med. 2003 Aug;5(8):645-53. doi: 10.1002/jgm.436. J Gene Med. 2003. PMID: 12898634 Review.
Cited by
-
Biallelic, Selectable, Knock-in Targeting of CCR5 via CRISPR-Cas9 Mediated Homology Directed Repair Inhibits HIV-1 Replication.Front Immunol. 2022 Mar 21;13:821190. doi: 10.3389/fimmu.2022.821190. eCollection 2022. Front Immunol. 2022. PMID: 35386712 Free PMC article.
-
Survival of the fittest: positive selection of CD4+ T cells expressing a membrane-bound fusion inhibitor following HIV-1 infection.PLoS One. 2010 Aug 23;5(8):e12357. doi: 10.1371/journal.pone.0012357. PLoS One. 2010. PMID: 20808813 Free PMC article.
-
Mesenchymal stem cells are attracted to latent HIV-1-infected cells and enable virus reactivation via a non-canonical PI3K-NFκB signaling pathway.Sci Rep. 2018 Oct 2;8(1):14702. doi: 10.1038/s41598-018-32657-y. Sci Rep. 2018. PMID: 30279437 Free PMC article.
-
RNA interference-based therapeutics for human immunodeficiency virus HIV-1 treatment: synthetic siRNA or vector-based shRNA?Expert Opin Biol Ther. 2010 Feb;10(2):201-13. doi: 10.1517/14712590903448158. Expert Opin Biol Ther. 2010. PMID: 20088715 Free PMC article. Review.
-
Genetic therapies against HIV.Nat Biotechnol. 2007 Dec;25(12):1444-54. doi: 10.1038/nbt1367. Nat Biotechnol. 2007. PMID: 18066041 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials